Diversigen, a portfolio company of Baylor College of Medicine, has been sold to OraSure Technologies
Client: Baylor College of Medicine
Client Location: United States
Target: Diversigen, Inc.
Target Location: United States
Buyer: OraSure Technologies (NASDAQ:OSUR)
Buyer Location: United States
Target Description: Diversigen is a leading provider of comprehensive, integrated and multidimensional insights into the diverse microbiomes of living organisms and environments.
Meet our Senior Team
View More Transactions
Lincoln is pleased to have advised UK-based Woodall Nicholson on its sale to UK-based private equity investor Rutland Partners
Lincoln International is pleased to announce that it advised founding shareholders in the sale of Acture Groep
Lincoln International has advised Profile Search & Selection in its sale to Wilson HCG, a portfolio company of CIP Capital
Lincoln International is pleased to announce that Sandbox Group has been sold to MERGE, a portfolio company of Keystone Capital